Beijing Tong Ren Tang Chinese Medicine Co Ltd
HKEX:3613
Intrinsic Value
The intrinsic value of one Beijing Tong Ren Tang Chinese Medicine Co Ltd stock under the Base Case scenario is 9.45 HKD. Compared to the current market price of 8.82 HKD, Beijing Tong Ren Tang Chinese Medicine Co Ltd is Undervalued by 7%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
Beijing Tong Ren Tang Chinese Medicine Co Ltd
Fundamental Analysis


Revenue & Expenses Breakdown
Beijing Tong Ren Tang Chinese Medicine Co Ltd
Balance Sheet Decomposition
Beijing Tong Ren Tang Chinese Medicine Co Ltd
Current Assets | 4B |
Cash & Short-Term Investments | 1.8B |
Receivables | 557m |
Other Current Assets | 1.6B |
Non-Current Assets | 593.8m |
Long-Term Investments | 62.2m |
PP&E | 428.8m |
Intangibles | 67.3m |
Other Non-Current Assets | 35.5m |
Free Cash Flow Analysis
Beijing Tong Ren Tang Chinese Medicine Co Ltd
HKD | |
Free Cash Flow | HKD |
Earnings Waterfall
Beijing Tong Ren Tang Chinese Medicine Co Ltd
Revenue
|
1.6B
HKD
|
Cost of Revenue
|
-546.3m
HKD
|
Gross Profit
|
1.1B
HKD
|
Operating Expenses
|
-488.4m
HKD
|
Operating Income
|
576.9m
HKD
|
Other Expenses
|
-76.6m
HKD
|
Net Income
|
500.3m
HKD
|
Profitability Score
Profitability Due Diligence
Beijing Tong Ren Tang Chinese Medicine Co Ltd's profitability score is 67/100. The higher the profitability score, the more profitable the company is.
Score
Beijing Tong Ren Tang Chinese Medicine Co Ltd's profitability score is 67/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Beijing Tong Ren Tang Chinese Medicine Co Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.
Score
Beijing Tong Ren Tang Chinese Medicine Co Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Beijing Tong Ren Tang Chinese Medicine Co Ltd
According to Wall Street analysts, the average 1-year price target for Beijing Tong Ren Tang Chinese Medicine Co Ltd is 11.88 HKD with a low forecast of 10.61 HKD and a high forecast of 13.44 HKD.
Dividends
Current shareholder yield for Beijing Tong Ren Tang Chinese Medicine Co Ltd is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one Beijing Tong Ren Tang Chinese Medicine Co Ltd stock under the Base Case scenario is 9.45 HKD.
Compared to the current market price of 8.82 HKD, Beijing Tong Ren Tang Chinese Medicine Co Ltd is Undervalued by 7%.